Get started
CELESTRACELESTRACELESTRA

CELESTRA

No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

352770 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Celestra, Inc. engages in the development and commercialization of cancer and disease early diagnosis technology services. Its products and services include COVID-19 test kits, liquid biopsy and precision medicine, health care, and big data. The company was founded on June 21, 2011 and is headquartered in Ulsan, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
352770 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company